Navigation Links
Atherotech Receives Patent for ApoB Measurement
Date:5/19/2009

Patent recognizes accurate method in the VAP(R) Cholesterol Test for determining heart disease risk

BIRMINGHAM, Ala., May 19 /PRNewswire/ -- Atherotech, Inc., developer of the VAP Cholesterol Test, has announced it has received a patent on its method to derive and report apolipoprotein B100 (apoB) using the Vertical Auto Profile (VAP) technology. The patent recognizes the unique ability of the VAP Cholesterol Test to accurately report apoB, the next milestone in heart disease risk assessment.

The patent, issued April 21, 2009, states that Atherotech provides a "system and method that measures the concentration of apoB without requiring a separate apoB specific test." Atherotech added apoB measurement to its VAP Test in 2007 and has since reported more than 1 million apoB results. The VAP Test is the only single cholesterol test that routinely reports apoB.

ApoB is a protein found on all atherogenic (bad) lipoproteins present in blood circulation, and elevated apoB values represent increased risk for heart disease. In numerous well-designed prospective studies, apoB has been shown to be superior to LDL cholesterol in predicting cardiovascular events and in following the progression of heart disease. ApoB is particularly valuable in hypertriglyceridemic and insulin-resistant states where LDL levels would be falsely reassuring and not representative of true atherosclerotic particle burden.

"ApoB is much more predictive of risk than LDL," noted Michael Cobble, M.D., director of Canyons Medical Center in Sandy, Utah. Cobble is a primary care physician, board-certified lipidologist and certified hypertension specialist. "It aligns with non-HDL and VLDL more accurately and is an important treatment target recently confirmed by both the American College of Cardiology and the American Diabetes Association."

People with a family history or an existing condition of diabe
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
2. Atherotech Unveils New Cardiometabolic Test Panels
3. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
4. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
5. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
6. VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
7. Atherotech to Exhibit the VAP Test at Internal Medicine 2008
8. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
9. Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
10. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
11. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... Institute (NEI), a division of the National Institutes of Health ... help fund its development of a non-invasive, passive diffusion-based treatment ... ... Salt Lake City, UT (PRWEB) December 10, 2009 ... National Institutes of Health (NIH), awarded a $2.18 million grant ...
(Date:12/10/2009)... China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... biopharmaceutical companies in China, today announced,that the Company,s ... at the,NASDAQ MarketSite in New York City at ... China Biologic,s common stock ... 2, 2009, under the ticker symbol "CBPO." , ...
(Date:12/10/2009)... DNDN ) today announced that Hans Bishop has ... 4, 2010. Mr. Bishop most recently served as ... he was responsible for a diverse portfolio of oncology, ... as an executive vice president of Bayer HealthCare LLC. ... management team, Mr. Bishop will be responsible for preparing ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2
... The Eniva Research Group has,released results ... Pauling,Micronutrient Research Institute at Oregon State University ... DNA protective,anti-mutagenic activity for human cells. This ... an ongoing investigative effort to further identify,mechanisms ...
... On June 27, 2008,GeneraMedix Inc. received approval ... its Epoprostenol for Injection 1.5 mg New Drug,Application ... indicated for the long-term,intravenous treatment of primary pulmonary ... of disease in NYHA,Class III and Class IV ...
... July 3 Advanced Life Sciences,Holdings, Inc. ... engaged in the,discovery, development and commercialization of ... cancer and respiratory diseases, today,announced that it ... after the,Russell Investment Group reconstituted its comprehensive ...
Other Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3
(Date:12/11/2009)... ROUGE, LAKeeping with the global "green" trend, ... education lessons to enhance students, science knowledge. ... into the curriculum raises not just science ... scores in other subject areas. Naturally, educators ... integrate these relevant lessons into the classroom ...
(Date:12/11/2009)... under stress collectively weigh and initiate different survival strategies ... make strategic decisions that affect their health, wealth and ... published this week in the early online edition of ... Sciences , was accomplished when the scientists applied the ... interplay of genes and proteins that colonies of bacteria ...
(Date:12/11/2009)... This release is available in French . ... have discovered a novel molecular mechanism that prevents cancer. ... Molecular Cell , scientists from the Universit de ... found that the SOCS1 molecule prevents the cancer-causing activity ... inflammation diseases such as Crohns, in smokers and people ...
Breaking Biology News(10 mins):Students learn environmental stewardship, improve science scores 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Scientists identify natural anti-cancer defenses 2Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 1Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 2Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 3Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 4Cell Therapeutics Inc 28CTI 29 Piper Jaffray Presentation to be Webcast 62317 1Childhood lead exposure causes permanent brain damage 62312 1Childhood lead exposure causes permanent brain damage 62312 2
... 2008] Three-quarters of youths with type 1 diabetes were ... a study by researchers at the Joslin Diabetes Center ... D supplementation to prevent bone fragility later in life. , ... D inadequacy," said Lori Laffel, M.D., M.P.H., Chief of the ...
... A newly published genome sequence of a breast ... blueprint involving breaks and fusions of genes and a ... of Medicine in a report that appears online in ... a computer program that has become buggy and transcends ...
... new family of fluorescent probes called hydrocyanines that can ... reactive oxygen species. Reactive oxygen species are highly reactive ... variety of inflammatory diseases, including cancer and atherosclerosis. , ... to detect the reactive oxygen species, superoxide and ...
Other Biology News:Joslin research finds nearly three-quarters of youths with diabetes insufficient in vitamin D 2Breast cancer genome shows evolution, instability of cancer 2Breast cancer genome shows evolution, instability of cancer 3Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 2Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 3
... The Jouan RCT series of refrigerated ... suited to trapping of low volatility/aqueous solvents ... with RC10 and other vacuum concentrators/centrifugal evaporators. ... in cooling systems such as used in ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
...
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
Biology Products: